Prevalence of sleep disorders in Parkinson's disease patients in two neurology referral hospitals in Ethiopia.
Africa
Parkinson’s disease
Poverty
Sleep disorders
Journal
BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555
Informations de publication
Date de publication:
22 Aug 2019
22 Aug 2019
Historique:
received:
21
12
2018
accepted:
23
07
2019
entrez:
24
8
2019
pubmed:
24
8
2019
medline:
26
11
2019
Statut:
epublish
Résumé
Non motor symptoms (NMS) of Parkinson's disease (PD) are common and can be more disabling than motor symptoms. Sleep disorders can be seen in up to 98% of patients with Parkinson disease. Poor sleep quality has been associated with poverty and race, and yet there has been no prior report on sleep disorders in those with PD living in sub Saharan Africa. We wished to document the prevalence of sleep disorders in PD patients in Ethiopia. We conducted a cross-sectional point prevalence study from July 1 to October 30, 2015 of all patients attending the neurology outpatient department in Tikur Anbessa and Zewuditu Memorial Hospitals, Addis Ababa, Ethiopia. Demographic data, clinical history and physical examination findings were collected from participants using a structured questionnaire. We used the Parkinson's disease sleep scale version two (PDSS-2) and Epworth Sleepiness Scale (ESS) to assess the sleep symptoms. Of the 155 patients surveyed, all patients reported some sleep problem. Over 43.9% of patients had a PDSS score > 18. The median score of ESS was 9 (IQR = 5-12), with 77/155 (49.7%) of the patients having possible or definite excessive daytime somnolence. A high EDSS score significantly associated with a Hoehn & Yahr score > 4 (p = 0.02). In Ethiopian PD patients, the prevalence of those with severe sleep disorders is the highest reported to date. The prevalence of possible/definite EDS is amongst the highest in the world. Further investigation into whether poverty or race explains this finding is needed.
Sections du résumé
BACKGROUND
BACKGROUND
Non motor symptoms (NMS) of Parkinson's disease (PD) are common and can be more disabling than motor symptoms. Sleep disorders can be seen in up to 98% of patients with Parkinson disease. Poor sleep quality has been associated with poverty and race, and yet there has been no prior report on sleep disorders in those with PD living in sub Saharan Africa. We wished to document the prevalence of sleep disorders in PD patients in Ethiopia.
METHODS
METHODS
We conducted a cross-sectional point prevalence study from July 1 to October 30, 2015 of all patients attending the neurology outpatient department in Tikur Anbessa and Zewuditu Memorial Hospitals, Addis Ababa, Ethiopia. Demographic data, clinical history and physical examination findings were collected from participants using a structured questionnaire. We used the Parkinson's disease sleep scale version two (PDSS-2) and Epworth Sleepiness Scale (ESS) to assess the sleep symptoms.
RESULTS
RESULTS
Of the 155 patients surveyed, all patients reported some sleep problem. Over 43.9% of patients had a PDSS score > 18. The median score of ESS was 9 (IQR = 5-12), with 77/155 (49.7%) of the patients having possible or definite excessive daytime somnolence. A high EDSS score significantly associated with a Hoehn & Yahr score > 4 (p = 0.02).
CONCLUSIONS
CONCLUSIONS
In Ethiopian PD patients, the prevalence of those with severe sleep disorders is the highest reported to date. The prevalence of possible/definite EDS is amongst the highest in the world. Further investigation into whether poverty or race explains this finding is needed.
Identifiants
pubmed: 31438888
doi: 10.1186/s12883-019-1431-2
pii: 10.1186/s12883-019-1431-2
pmc: PMC6706909
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
205Références
Neurology. 2003 Sep 23;61(6 Suppl 3):S17-23
pubmed: 14504376
Sleep Med. 2010 Mar;11(3):247-52
pubmed: 19628429
Sleep Med Rev. 2003 Apr;7(2):115-29
pubmed: 12628213
J Neurol. 2011 Sep;258(9):1649-56
pubmed: 21442463
J Neuropsychiatry Clin Neurosci. 2002 Spring;14(2):223-36; discussion 222
pubmed: 11983801
Clin Neuropharmacol. 1988 Dec;11(6):512-9
pubmed: 3233589
Age Ageing. 2006 May;35(3):220-8
pubmed: 16638765
Mov Disord. 2002 Jul;17(4):775-81
pubmed: 12210875
J Neurosci Rural Pract. 2012 Sep;3(3):233-4
pubmed: 23188965
Mov Disord. 2006 Dec;21(12):2150-6
pubmed: 17044056
Sleep. 1991 Dec;14(6):540-5
pubmed: 1798888
Mov Disord. 2008 Jul 30;23(10):1378-83
pubmed: 18546341
Mov Disord. 2002 Sep;17(5):1026-30
pubmed: 12360553
Mov Disord. 2007 Aug 15;22(11):1623-9
pubmed: 17546669
BMC Neurol. 2010 Jan 05;10:1
pubmed: 20051133
Mov Disord. 2011 Mar;26(4):644-52
pubmed: 21312275
East Afr Med J. 1985 Aug;62(8):571-9
pubmed: 4054032
Mov Disord. 2005 Sep;20(9):1209-13
pubmed: 15954128
Neurology. 2005 Jun 28;64(12 Suppl 3):S12-20
pubmed: 15994219
J Neurol Neurosurg Psychiatry. 2002 Dec;73(6):629-35
pubmed: 12438461
Sleep Med. 2003 Jul;4(4):339-42
pubmed: 14592307
J Am Geriatr Soc. 1997 Feb;45(2):194-9
pubmed: 9033518
Mov Disord. 2010 May 15;25(7):906-11
pubmed: 20175212
Arq Neuropsiquiatr. 2015 Mar;73(3):241-5
pubmed: 25807131
Mov Disord. 1998 Nov;13(6):895-9
pubmed: 9827612
Neurology. 2001 Oct 23;57(8):1392-6
pubmed: 11673578
Ther Adv Neurol Disord. 2009 Jul;2(4):205-14
pubmed: 21179529
BMC Public Health. 2011 Apr 08;11:219
pubmed: 21477284
Int J Hypertens. 2011;2011:193719
pubmed: 21747973
Mov Disord. 1999 Nov;14(6):922-7
pubmed: 10584665
BMC Public Health. 2010 Aug 11;10:475
pubmed: 20701789
Mov Disord. 2003 Mar;18(3):319-323
pubmed: 12621636
Mov Disord. 2008 Aug 15;23(11):1567-672
pubmed: 18581482
PLoS One. 2014 Sep 08;9(9):e107278
pubmed: 25198548
Mov Disord. 2003 Jun;18(6):668-72
pubmed: 12784270